Screener
Rapport Therapeutics, Inc. RAPP Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Rapport Therapeutics, Inc.’s 10-K, filed March 10, 2026.
- Filed
- Mar 10, 2026, 7:25 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-099360
| Line item | For the year ended December 31, 2025 | For the year ended December 31, 2024 |
|---|---|---|
| Operating lease | ||
| Operating lease right-of-use assets, net | $9,909 | $1,442 |
| Operating lease right-of-use liabilities, current | 2,755 | 737 |
| Operating lease right-of-use liabilities, non-current | 8,729 | 739 |
| Total operating lease liabilities | $11,484 | $1,476 |
Item 8. Financial Statements and Supplementary Data.
FAQ
- What is Rapport Therapeutics, Inc.'s operating lease liabilities (total)?
- Rapport Therapeutics, Inc. (RAPP) reported operating lease liabilities (total) of $11.48M in Q4 2025.
- What is the long-term trend for Rapport Therapeutics, Inc.'s operating lease liabilities (total)?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s operating lease liabilities (total) has grown at a 131.3% compound annual growth rate (CAGR), from $2.15M to $11.48M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Rapport Therapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude